Colgate-Palmolive net sales hit USD 5.32 B in Q1 FY26

USA – Colgate-Palmolive reported solid first-quarter 2026 results, with net sales rising 8.4% year-on-year to about USD 5.32 billion and organic sales up 2.9%, underscoring broad-based growth across key categories and most business divisions. 

The 2.9% organic sales increase reflected roughly 1.1% overall volume growth and a 2.2% uplift from pricing, partially offset by an estimated 0.6 percentage-point drag tied to lower private-label pet food sales. 

Management highlighted that net and organic sales rose across oral care, personal care, home care and pet nutrition, with four of five operating divisions delivering organic growth and emerging markets providing a strong underpinning for the quarter.

Regionally, North America contributed about USD 888 million in sales and saw organic sales decline 2.2% (volume down 3.2%, price up 1.0%), while Latin America delivered approximately USD 1,313 million in sales with 5.4% organic growth, EMEA generated around USD 1,126 million with 3.5% organic growth, Asia Pacific reported USD 804 million with 5.6% organic growth, and Hill’s Pet Nutrition posted USD 1,194 million in sales with 2.1% organic growth.

On earnings, Colgate-Palmolive’s GAAP net income for the quarter was about USD 646 million, down from roughly USD 690 million a year earlier, with diluted GAAP earnings per share decreasing 6% to USD 0.80. 

In contrast, Base Business (non-GAAP) EPS increased 7% to USD 0.97, beating consensus estimates of USD 0.94–0.95 and reflecting solid underlying profit growth after excluding one-time items. 

The company reported that both GAAP and Base Business gross profit margins were 60.6% for the quarter, down 20 basis points from the prior-year period, while adjusted operating margin on a Base Business basis slipped to 21.3%, about 90 basis points lower than in Q1 2025. 

Despite these margin pressures, driven largely by higher raw material and logistics costs, as well as the impact of tariffs and the Middle East conflict, Colgate generated a robust USD 747 million in operating cash flow, underscoring strong cash generation to support brand investment, productivity initiatives, and shareholder distributions.

To offset cost inflation and fund its long-term growth agenda, Colgate-Palmolive expanded its Strategic Growth and Productivity Program, now expecting cumulative pretax charges of USD 350-550 million, up from a previous estimate of roughly USD 200–300 million. 

The company anticipates that, once fully executed, this program will deliver annual pretax savings of around USD 200–300 million, with benefits skewed towards the period beyond 2026 as initiatives ramp up. 

At the same time, Colgate stepped up brand-building activity, lifting advertising and related investments to about USD 734 million in the quarter, an increase of roughly 10% year-on-year, to support its global franchises in toothpaste, manual toothbrushes and broader personal and home care. 

Noel Wallace, Chairman, President, and Chief Executive Officer, commented on the Base Business first-quarter results, “We delivered a strong start to 2026, with broad-based top and bottom-line growth.”

“These results underscore the resilience of our business model as we are able to execute against our long-term strategy while delivering strong results in a difficult operating environment.”

Looking ahead, Colgate-Palmolive reaffirmed its full-year 2026 guidance for net sales growth of 2% to 6%, including a low-single-digit foreign-exchange tailwind, and organic sales growth of approximately 1% to 4%. 

The company continues to expect low- to mid-single-digit Base Business EPS growth, even as it now anticipates full-year gross margin to be down versus prior-year comparisons, a revision from earlier expectations of margin expansion, due to higher anticipated raw material and logistics expenses estimated at around USD 300 million for the year. 

Colgate also reiterated its long-standing dividend practice, with the board recently declaring a quarterly cash dividend of USD 0.53 per share, payable in August 2026, underscoring its commitment to returning cash to shareholders while continuing to invest in innovation and productivity. 

The company stressed that strong emerging-market growth, category leadership in oral care, disciplined capital allocation and the ramp-up of productivity savings should help it navigate continued macroeconomic volatility and cost pressures while sustaining growth in its core everyday consumer franchises through the remainder of 2026.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.